Found: 54
Select item for more details and to access through your institution.
Dacomitinib overcomes afatinib-refractory carcinomatous meningitis in a lung cancer patient harbouring EGFR Ex.19 deletion and G724S mutation; a case report.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1137, doi. 10.1007/s10637-022-01264-0
- By:
- Publication type:
- Article
Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 232, doi. 10.1007/s10637-020-00966-7
- By:
- Publication type:
- Article
Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reaction.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1138, doi. 10.1007/s10637-018-0628-3
- By:
- Publication type:
- Article
Successful weaning of a patient with severe COVID-19 pneumonia under prolonged midazolam sedation using morphine.
- Published in:
- Oxford Medical Case Reports, 2022, v. 2022, n. 6, p. 1, doi. 10.1093/omcr/omac051
- By:
- Publication type:
- Article
Gene therapy utilizing the Cre/ loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells.
- Published in:
- International Journal of Cancer, 2001, v. 94, n. 3, p. 414, doi. 10.1002/ijc.1474
- By:
- Publication type:
- Article
Adenovirus-mediated gene therapy specific for small cell lung cancer cells using a Myc-Max binding motif.
- Published in:
- International Journal of Cancer, 2001, v. 91, n. 6, p. 851, doi. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1120>3.0.CO;2-1
- By:
- Publication type:
- Article
Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192227
- By:
- Publication type:
- Article
Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02749-1
- By:
- Publication type:
- Article
Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 167, n. 3, p. 397, doi. 10.1007/s11060-024-04616-3
- By:
- Publication type:
- Article
A Retrospective Study of the Novel Combination of Paclitaxel and S1 for Pretreated Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 58, n. 6, p. 454, doi. 10.1159/000345624
- By:
- Publication type:
- Article
Randomized Phase II Study of Two Schedules of Carboplatin and Gemcitabine for Stage IIIB and IV Advanced Non-Small Cell Lung Cancer (JACCRO LC-01 Study).
- Published in:
- Chemotherapy (0009-3157), 2011, v. 57, n. 4, p. 357, doi. 10.1159/000330481
- By:
- Publication type:
- Article
Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer.
- Published in:
- Oncogene, 2003, v. 22, n. 5, p. 674, doi. 10.1038/sj.onc.1206106
- By:
- Publication type:
- Article
Downregulation of EGFR in a metastatic brain lesion of EGFR-mutated non-small cell lung cancer using a tyrosine kinase inhibitor: A case report.
- Published in:
- Oncology Letters, 2017, v. 13, n. 4, p. 2085, doi. 10.3892/ol.2017.5677
- By:
- Publication type:
- Article
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 79, doi. 10.1007/s10147-022-02266-x
- By:
- Publication type:
- Article
Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 3, p. 600, doi. 10.1007/s10147-016-1081-y
- By:
- Publication type:
- Article
Analysis of Early Death in Japanese Patients With Advanced Non-small-cell Lung Cancer Treated With Nivolumab.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 13, p. 4501, doi. 10.1002/cam4.3089
- By:
- Publication type:
- Article
Multiplex gene‐panel testing for lung cancer patients.
- Published in:
- Pathology International, 2020, v. 70, n. 12, p. 921, doi. 10.1111/pin.13023
- By:
- Publication type:
- Article
Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case report.
- Published in:
- BMC Pharmacology & Toxicology, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s40360-020-00404-7
- By:
- Publication type:
- Article
Exceptionally long‐lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD‐L1: A case report.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 11, p. 929, doi. 10.1111/1759-7714.15254
- By:
- Publication type:
- Article
Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR‐mutated lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 22, p. 2210, doi. 10.1111/1759-7714.15038
- By:
- Publication type:
- Article
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 1, p. 85, doi. 10.1111/1759-7714.14738
- By:
- Publication type:
- Article
Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single‐center retrospective study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2970, doi. 10.1111/1759-7714.14643
- By:
- Publication type:
- Article
Quantitative Identification of Mutant Alleles Derived from Lung Cancer in Plasma Cell-Free DNA via Anomaly Detection Using Deep Sequencing Data.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081468
- By:
- Publication type:
- Article
Transient appearance of circulating tumor DNA associated with de novo treatment.
- Published in:
- Scientific Reports, 2016, p. 38639, doi. 10.1038/srep38639
- By:
- Publication type:
- Article
Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients.
- Published in:
- Scientific Reports, 2016, p. 29093, doi. 10.1038/srep29093
- By:
- Publication type:
- Article
A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
- By:
- Publication type:
- Article
A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
- By:
- Publication type:
- Article
Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920904522
- By:
- Publication type:
- Article
Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulants.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cam4.7430
- By:
- Publication type:
- Article
Comparison of sampling methods for next generation sequencing for patients with lung cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 14, p. 2744, doi. 10.1002/cam4.4632
- By:
- Publication type:
- Article
The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89006-9
- By:
- Publication type:
- Article
A Phase II Study of Pemetrexed in Chemotherapy-naïve Elderly Patients Aged ≥75 years with Advanced Non-squamous Non-small-cell Lung Cancer (HANSHIN Oncology Group 003).
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 12, p. 1184, doi. 10.1093/jjco/hyt159
- By:
- Publication type:
- Article
Influence of Thoracic Radiotherapy on Exhaled Nitric Oxide Levels in Patients with Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2001, v. 31, n. 4, p. 142, doi. 10.1093/jjco/hye028
- By:
- Publication type:
- Article
Effectiveness of EGFR tyrosine kinase inhibitors in advanced non‐small cell lung cancer patients with uncommon EGFR mutations: A multicenter observational study.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 1, p. 90, doi. 10.1111/1759-7714.13718
- By:
- Publication type:
- Article
HER3 expression is enhanced during progression of lung adenocarcinoma without <italic>EGFR</italic> mutation from stage 0 to IA1.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 4, p. 466, doi. 10.1111/1759-7714.12609
- By:
- Publication type:
- Article
Delayed pseudoprogression of lung adenocarcinoma accompanied with interstitial lung disease during chemotherapy after nivolumab treatment.
- Published in:
- Thoracic Cancer, 2017, v. 8, n. 3, p. 275, doi. 10.1111/1759-7714.12431
- By:
- Publication type:
- Article
Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA.
- Published in:
- Clinical Chemistry, 2015, v. 61, n. 9, p. 1191, doi. 10.1373/clinchem.2015.241414
- By:
- Publication type:
- Article
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03583-4
- By:
- Publication type:
- Article
Osimertinib for patients with EGFR T790M mutation-positive non–small-cell lung cancer and a poor performance status.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 7, p. 671, doi. 10.1093/jjco/hyz041
- By:
- Publication type:
- Article
Pleural sarcoidosis diagnosed on the basis of an increased CD4/CD8 lymphocyte ratio in pleural effusion fluid: a case report.
- Published in:
- Journal of Medical Case Reports, 2015, v. 9, n. 1, p. 1, doi. 10.1186/s13256-015-0656-y
- By:
- Publication type:
- Article
Pleural sarcoidosis diagnosed on the basis of an increased CD4/CD8 lymphocyte ratio in pleural effusion fluid: a case report.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512)
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 5, p. 2327, doi. 10.1007/s00520-020-05765-7
- By:
- Publication type:
- Article
Fragment size and dynamics of EGFR-mutated tumor-derived DNA provide prognostic information regarding EGFR-TKI efficacy in patients with EGFR-mutated NSCLC.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17848-y
- By:
- Publication type:
- Article
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Novel Chemoradiotherapy With Concomitant Boost Thoracic Radiation and Concurrent Cisplatin and Vinorelbine for Stage IIIA and IIIB Non-Small-Cell Lung Cancer.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Novel Chemoradiotherapy With Concomitant Boost Thoracic Radiation and Concurrent Cisplatin and Vinorelbine for Stage IIIA and IIIB Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 4, p. 281, doi. 10.1016/j.cllc.2014.02.001
- By:
- Publication type:
- Article
Impact of in vitro chemosensitivity test-guided platinum-based adjuvant chemotherapy on the surgical outcomes of patients with p-stage IIIA non-small cell lung cancer that underwent complete resection.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 3, p. 327, doi. 10.3892/mco.2017.1340
- By:
- Publication type:
- Article
Protein and mRNA expression of folic acid-associated enzymes as biomarkers for the cytotoxicity of the thymidylate synthase-targeted drugs, pemetrexed and S-1, in non-small cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 1, p. 15, doi. 10.3892/mco.2017.1262
- By:
- Publication type:
- Article
CMET-38. IMPACT ON THE CLINICAL COURSE OF EGFR MUTATION ON BRAIN METASTASES FROM NON-SMALL-CELL LUNG CANCER FROM VIEWPOINT OF NEURO-ONCOLOGISTS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi61, doi. 10.1093/neuonc/noy148.248
- By:
- Publication type:
- Article